Clinical Trial Update: Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on reducing cardiovascular disease risk by combining smoking cessation pharmacotherapy with behavioral counseling. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Smoking Cessation, Psychiatric Illness | Phase 4 | Status: COMPLETED